Hagit Padova
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 2
- Health top 10%
- Vaccine Coverage and Hesitancy 3
- Modeling and Simulation top 10%
-
- Cancer Immunotherapy and Biomarkers 2
- COVID-19 and healthcare impacts 2
-
- Cardiac Arrest and Resuscitation 2
- Trauma and Emergency Care Studies 2
-
- Systemic Lupus Erythematosus Research 2
In The Last Decade
Hagit Padova
12 papers receiving 358 citations
Peers
Comparison fields: 5 of 47
- Infectious Diseases 229
- Health 83
- Modeling and Simulation 31
- Hematology 57
- Oncology 98
Countries citing papers authored by Hagit Padova
This map shows the geographic impact of Hagit Padova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hagit Padova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hagit Padova more than expected).
Fields of papers citing papers by Hagit Padova
This network shows the impact of papers produced by Hagit Padova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hagit Padova. The network helps show where Hagit Padova may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hagit Padova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors (vol 22, pg 581, 2021) | 2021 | 2 |
| 5 | 2021 | 117 | |
| 6 | 2021 | 10 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 126 | |
| 9 | 2018 | 1 | |
| 10 | 2016 | 15 | |
| 11 | 2014 | 35 | |
| 12 | 2014 | 40 | |
| 13 | 2007 | 17 | |
| 14 | Small bowel bleeding as a unique presentation of metastatic lung carcinoma. | 2004 | 1 |
About Hagit Padova
Hagit Padova is a scholar working on Health, Emergency Medicine and Emergency Medical Services, having authored 14 papers that have together received 366 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Vaccine Coverage and Hesitancy (3 papers), Cardiac Arrest and Resuscitation (2 papers), COVID-19 Clinical Research Studies (2 papers), Systemic Lupus Erythematosus Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Trauma and Emergency Care Studies (2 papers) and COVID-19 and healthcare impacts (2 papers). The work is most often cited by research in Infectious Diseases (229 citations), Health (83 citations) and Modeling and Simulation (31 citations). Hagit Padova has collaborated with scholars based in Israel, Australia and Japan. Frequent co-authors include Barliz Waissengrin, Ido Wolf, Abed Agbarya, Esther Saiag, Yoel Angel, Ronen Ben‐Ami, Oryan Henig, Eli Sprecher, Avishay Spitzer and Ori Elkayam. Their work appears in journals such as JAMA, The Lancet Oncology and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.